To include your compound in the COVID-19 Resource Center, submit it here.

Inavir laninamivir: Phase III data

A double-blind, Japanese Phase III trial in >1,500 healthy family members of a patient with confirmed influenza infection A or B infection showed that

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE